Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 8:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 2,351 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Covid 19 Clear all

Conditions: COVID-19, Pregnancy Complications
Interventions: Not listed
Lead sponsor: The George Washington University Biostatistics Center; Other
Eligibility: Female only
Enrollment: 25,604 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 12
States / cities: Birmingham, Alabama • Chicago, Illinois • New York, New York + 9 more

Conditions: Educational Activities
Interventions: Text Messaging Only, INFORMED; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 247 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Fresno, California • San Francisco, California • San Jose, California

Conditions: Sars-CoV-2, Covid19
Interventions: BLD-2660; Drug
Lead sponsor: Blade Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 27
States / cities: Irvine, California • Los Angeles, California • San Jose, California + 23 more

Conditions: COVID 19, SARS-CoV 2, Pneumonia
Interventions: Mavrilimumab, Placebos; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 2
States / cities: Weston, Florida • Cleveland, Ohio

Conditions: COVID-19
Interventions: Hydroxychloroquine (HCQ); Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: SARS-CoV-2
Interventions: Diagnostic test for detection of SARS-CoV-2; Diagnostic Test
Lead sponsor: Illumina, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 644 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Winter Park, Florida

Conditions: Healthy, Chronic Stable Illness
Interventions: REGN10933+REGN10987, Placebo; Drug
Lead sponsor: Regeneron Pharmaceuticals; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 974 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 7
States / cities: Tempe, Arizona • Rogers, Arkansas • Sacramento, California + 4 more

Conditions: COVID-19
Interventions: RD-X19, Sham; Device
Lead sponsor: EmitBio Inc.; Industry
Eligibility: 40 Years and older
Enrollment: 330 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 48
States / cities: Mesa, Arizona • Phoenix, Arizona • Anaheim, California + 42 more

Conditions: Covid19, Cardiac Disease, Cardiac Arrhythmia, Myocarditis, Left Ventricular Dysfunction
Interventions: Transthoracic echocardiogram (TTE), Cardiovascular Magnetic Resonance (CMR) Imaging; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 52 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19 Infection
Interventions: Questionnaire Administration; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: SARS-CoV-2
Interventions: Standard of Care (SOC) and Colchicine+Rosuvastatin; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 4
States / cities: Bridgeport, Connecticut • Greenwich, Connecticut • New Haven, Connecticut + 1 more

Conditions: Coronavirus Infection
Interventions: No intervention; Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 5,154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Covid19, Community-Acquired Respiratory Tract Infection
Interventions: Observational measurement of biometric data. No change to health care provided.; Device
Lead sponsor: Health Stream Analytics, LLC; Industry
Eligibility: Not listed
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Pasco, Washington

Conditions: Healthy Participants
Interventions: Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF, QIV, Normal Saline Placebo; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 65 Years and older
Enrollment: 1,142 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 37
States / cities: Dublin, California • Huntington Beach, California • Lake Forest, California + 26 more

Conditions: Long COVID, Post Acute Sequelae of COVID-19
Interventions: 11C-PS13; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 70 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: SARS-CoV Infection
Interventions: Losartan; Drug
Lead sponsor: Sharp HealthCare; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 3
States / cities: La Mesa, California • San Diego, California

Conditions: COVID-19 Respiratory Infection, Influenza A, Influenza Type B, RSV Infection
Interventions: Labcorp COVID-19+Flu+RSV Test Home Collection Kit; Device
Lead sponsor: Sequenom, Inc.; Industry
Eligibility: 2 Years to 89 Years
Enrollment: 1,600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Pasadena, California

Conditions: X-linked Agammaglobulinemia, XLA, Primary Immune Deficiency, CVID, Common Variable Immunodeficiency, Primary Antibody Deficiencies, Secondary Hypogammaglobulinemia
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 6 Months and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 3
States / cities: St. Petersburg, Florida • Chapel Hill, North Carolina • Durham, North Carolina

Conditions: Post-COVID-19 Syndrome, Fatigue Syndrome, Chronic
Interventions: Anhydrous Enol-Oxaloacetate, a "Medical Food", White Rice Flour; Other
Lead sponsor: Terra Biological LLC; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: COVID-19
Interventions: LY3819253, LY3832479, LY3853113, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 0 Years and older
Enrollment: 3,307 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 12
States / cities: Redondo Beach, California • Miami, Florida • Union City, Georgia + 9 more

Conditions: Advanced Care Planning, Shared Decision Making, Video Decision Aids, Communication Skills, Advance Directives, Natural Language Processing, Covid19
Interventions: VitalTalk communication skills training, ACP Decisions Video Program, Intervention training:, Medical Record Review; Other
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 65 Years and older
Enrollment: 42,019 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: COVID-19, Coronavirus Infection, Corona Virus Infection
Interventions: Blood draw; Procedure
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: COVID-19
Interventions: Health Education Initiative; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Acute Respiratory Distress Syndrome, Coronavirus Infection
Interventions: vadadustat, placebo; Drug
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 448 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Maternal Morbidity and Mortality During the COVID-19 Pandemic

Getting Asian Americans INFORMED to Facilitate COVID-19 Testing and Vaccination

Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects

Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation

COVID-19 PrEP HCW HCQ Study

Evaluation of the COVIDSeq Test in Nasal Swab and Saliva From a COVID-19 Asymptomatic Population

Study Assessing the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Repeated Subcutaneous Doses of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies (REGN10933+REGN10987) in Adult Volunteers as Related to COVID-19

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry

Assessment of the Psychosocial Impact of the COVID-19 Pandemic on the MD Anderson Cancer Center Workforce

Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Non-invasive Biometric Monitoring in Nursing Homes to Fight COVID-19

A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit

COVID-19 Vaccine Responses in PIDD Subjects

REGAIN: RCT of Oxaloacetate for Fatigue in Long COVID

A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

Advance Care Planning: Communicating With Outpatients for Vital Informed Decision

Acquiring Convalescent Specimens for COVID-19 Antibodies

Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety

Vadadustat for the Prevention and Treatment of Acute Respiratory Distress Syndrome (ARDS) in Hospitalized Patients With Coronavirus Disease 2019 (COVID-19)